摘要
目的检测4种结缔组织病患者血清中血管内皮细胞生长因子(VEGF)水平,并探讨其意义。方法115例患者中,类风湿关节炎(RA)40例,系统性红斑狼疮(SLE)30例,多发性肌炎/皮肌炎(PM/DM)25例,系统性硬化症(SSc)20例,正常对照30例,采用酶联免疫吸附试验(ELISA)方法检测了血清中的VEGF(ng/L)的含量。结果血清VEGF水平(单位ng/L)分别为RA558.58±348.45,SLE244.63±87.44,PM/DM355.12±258.56,SSc362.72±177.52,类风湿关节炎、系统性红斑狼疮、多发性肌炎/皮肌炎、系统性硬化症患者血清VEGF水平均明显高于正常对照(P<0.01,P<0.05)。结论血清VEGF水平的测定对结缔组织病病情监测可能具有非常重要意义。
Objective To know the clinical significance of serum vascular endothelial growth factor (VEGF) level in connective tissue diseases. Methods The concentration of VEGF were determined in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), polymyositis/dermatomyositis (PM/DM ) or systemic sclerosis (SSc) and in normal control by ELISA. Results The serum concentrations of VEGF of RA, PM/DM or SSc were significantly higher than that of normal controls respectively (P<0.01). The serum VEGF level of SLE was significantly higher than that of normal controls (P<0.05). Conclusion The measurement of serum concentration of VEGF is a noninvasive, useful method for monitoring the disease activities of connective tissue diseases.
出处
《江西医学检验》
2004年第5期401-402,共2页
Jiangxi Journal of Medical Laboratory Sciences
关键词
患者
血清
结缔组织病
VEGF
系统性硬化症
正常
皮肌炎
水平
结论
重要意义
Vascular endothelial growth factor
Rheumatoid arthritis
Systemic lupus erythematosus
Polymyositis/Dermatomyositis
Systemic sclerosis